Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
FORTISNSE
ASTERDMNSE
MEDANTANSE
NHNSE
KIMSNSE
LALPATHLABNSE
VIJAYANSE
KRSNAANSE
Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 17% | 8% |
| - | - | 18% | 31% |
| - | -7% | -5% | -35% |
| 9% | 9% | 9% | 11% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
FORTIS
ASTERDM
MEDANTA
NH
KIMS
LALPATHLAB
VIJAYA
KRSNAA
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,888.5 | ₹130273 Cr | 62.35 | 40.39 | 207.67 | ₹1942 Cr |
| 1,046 | ₹102446 Cr | 70.32 | 3.31 | 19.84 | ₹1442 Cr |
| 742.5 | ₹100021 Cr | 112.09 | 1.96 | 11.95 | ₹892 Cr |
| 877.35 | ₹67267 Cr | 64.19 | 3.53 | 20.1 | ₹1042 Cr |
| 768.65 | ₹66295 Cr | 208.03 | 0.31 | 6.76 | ₹388 Cr |
| 1,506.2 | ₹40209 Cr | 72.3 | 5.91 | 29.85 | ₹556 Cr |
| 1,877.7 | ₹39270 Cr | 48.12 | 10.14 | 65.36 | ₹806 Cr |
| 802 | ₹33529 Cr | 164.12 | 1.04 | 12.74 | ₹241 Cr |
| 1,961.3 | ₹32271 Cr | 59.55 | 10.11 | 42.51 | ₹505 Cr |
| 1,526.5 | ₹16149 Cr | 86.13 | 5.16 | 27.53 | ₹173 Cr |
| 551 | ₹1815 Cr | 18.63 | 5.1 | 59.88 | ₹101 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| ₹8 Cr | ₹6 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| ₹956 Cr | ₹860 Cr | ₹791 Cr | ₹720 Cr | ₹667 Cr |
| ₹956 Cr | ₹860 Cr | ₹791 Cr | ₹720 Cr | ₹667 Cr |
| ₹980 Cr | ₹883 Cr | ₹810 Cr | ₹739 Cr | ₹684 Cr |
| ₹437 Cr | ₹19 Cr | ₹6 Cr | ₹11 Cr | ₹20 Cr |
| ₹25 Cr | ₹19 Cr | ₹15 Cr | ₹11 Cr | ₹7 Cr |
| ₹98 Cr | ₹49 Cr | ₹57 Cr | ₹47 Cr | ₹43 Cr |
| ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹32 L |
| ₹563 Cr | ₹90 Cr | ₹79 Cr | ₹71 Cr | ₹70 Cr |
| — | — | — | — | — |
| ₹63 Cr | ₹97 Cr | ₹82 Cr | ₹62 Cr | ₹77 Cr |
| ₹189 Cr | ₹60 Cr | ₹99 Cr | ₹35 Cr | ₹42 Cr |
| ₹11 Cr | ₹139 Cr | ₹96 Cr | ₹0 | ₹0 |
| ₹12 Cr | ₹9 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr |
| ₹275 Cr | ₹305 Cr | ₹281 Cr | ₹99 Cr | ₹121 Cr |
| ₹1819 Cr | ₹1278 Cr | ₹1170 Cr | ₹909 Cr | ₹875 Cr |
| ₹66 Cr | ₹55 Cr | ₹23 Cr | ₹4 Cr | ₹4 Cr |
| ₹491 Cr | ₹166 Cr | ₹107 Cr | ₹17 Cr | ₹26 Cr |
| — | — | — | — | — |
| ₹1042 Cr | ₹971 Cr | ₹874 Cr | ₹627 Cr | ₹491 Cr |
| ₹386 Cr | ₹300 Cr | ₹226 Cr | ₹156 Cr | ₹106 Cr |
| ₹656 Cr | ₹670 Cr | ₹647 Cr | ₹471 Cr | ₹386 Cr |
| ₹208 Cr | ₹3 Cr | ₹10 Cr | ₹25 Cr | ₹28 Cr |
| ₹57 Cr | ₹32 Cr | ₹29 L | ₹29 L | ₹29 L |
| ₹57 Cr | ₹32 Cr | ₹29 L | ₹29 L | ₹29 L |
| ₹124 Cr | ₹45 Cr | ₹62 Cr | ₹26 Cr | ₹18 Cr |
| ₹35 Cr | ₹114 Cr | ₹29 Cr | ₹163 Cr | ₹109 Cr |
| ₹1080 Cr | ₹864 Cr | ₹749 Cr | ₹686 Cr | ₹541 Cr |
| — | — | — | — | — |
| ₹27 Cr | ₹29 Cr | ₹36 Cr | ₹25 Cr | ₹9 Cr |
| ₹296 Cr | ₹278 Cr | ₹176 Cr | ₹73 Cr | ₹58 Cr |
| ₹361 Cr | ₹68 Cr | ₹175 Cr | ₹109 Cr | ₹242 Cr |
| ₹24 Cr | ₹30 Cr | ₹24 Cr | ₹10 Cr | ₹8 Cr |
| ₹31 Cr | ₹9 Cr | ₹10 Cr | ₹6 Cr | ₹17 Cr |
| ₹738 Cr | ₹414 Cr | ₹421 Cr | ₹223 Cr | ₹334 Cr |
| ₹463 Cr | ₹109 Cr | ₹140 Cr | ₹124 Cr | ₹213 Cr |
| ₹1819 Cr | ₹1278 Cr | ₹1170 Cr | ₹909 Cr | ₹875 Cr |
| ₹300 | ₹271 | ₹250 | ₹234 | ₹217 |
| ₹300 | ₹271 | ₹250 | ₹234 | ₹217 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| ₹130 Cr | ₹103 Cr | ₹70 Cr | ₹80 Cr | ₹87 Cr |
| ₹87 Cr | ₹98 Cr | ₹70 Cr | ₹45 Cr | ₹49 Cr |
| -₹47 Cr | -₹93 Cr | -₹97 Cr | -₹36 Cr | -₹66 L |
| ₹171 Cr | ₹107 Cr | ₹43 Cr | ₹89 Cr | ₹135 Cr |
| ₹143 Cr | ₹87 Cr | ₹24 Cr | ₹76 Cr | ₹128 Cr |
| -₹396 Cr | -₹100 Cr | -₹129 Cr | -₹109 Cr | -₹241 Cr |
| ₹279 Cr | ₹14 Cr | ₹84 Cr | -₹33 Cr | ₹176 Cr |
| ₹26 Cr | ₹1 Cr | -₹20 Cr | -₹66 Cr | ₹64 Cr |
| ₹4 Cr | ₹2 Cr | ₹23 Cr | ₹88 Cr | ₹25 Cr |
| ₹30 Cr | ₹4 Cr | ₹2 Cr | ₹23 Cr | ₹88 Cr |
Fundamental Ratios
Consolidated
Standalone
Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
49.06Neutral
STOCH %K
35.96Neutral
MACD Level(12,26)
-0.83Sell
Ultimate Oscillator
37.00Sell
Aroon Oscillator
66.00Buy
BOP
-0.88Sell
CCI
7.31Neutral
Williams %R
-64.04Neutral
Momentum
0.30Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 1
Bearish signals: 8 out of 9 moving averages
EMA 9
552.11Sell
SMA 9
548.23Buy
EMA 21
552.82Sell
SMA 21
554.03Sell
EMA 50
553.96Sell
SMA 50
552.22Sell
EMA 200
603.72Sell
SMA 200
607.71Sell
WMA 20
551.84Sell
Pivot
Pivot
Classic
Resistance 5
604.88
Resistance 4
594.08
Resistance 3
583.28
Resistance 2
572.48
Resistance 1
566.27
Pivot
561.68
Support 1
555.47
Support 2
550.88
Support 3
540.08
Support 4
529.28
Support 5
518.48
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 27.11% | 27.11% | 27.11% | 27.11% | 27.11% | 27.24% |
| 4.28% | 3.91% | 4.17% | 3.66% | 3.40% | 3.55% |
| 4.34% | 3.72% | 3.70% | 4.50% | 4.61% | 4.90% |
| 10.17% | 10.17% | 10.15% | 10.46% | 9.63% | 9.36% |
| 54.10% | 55.09% | 54.87% | 54.27% | 55.25% | 54.95% |
Bulk & block deals
Name
Hdfc Life Insurance Company Limited
Hdfc Life Insurance Company Limited
Kitara Piin 1104
East Lane Capital Llp
Medimaze Solutions Private Limited
Miv Investment Services Private Limited
Invesco Mutual Fund
Acm Global Fund Vcc
Somerset Indus Healthcare Fund I Limited
Birla Sun Life Insurance Co Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 15 Jun 2026 | Purchase | 15.13 Cr | ₹539.25 | 2.81 L | Bulk | 0.86497 | BSE |
| 15 Jun 2026 | Sell | 15.13 Cr | ₹539.25 | 2.81 L | Bulk | 0.86497 | BSE |
| 12 Jun 2024 | Sell | 22.35 Cr | ₹600.69 | 3.72 L | Bulk | 1.146778 | NSE |
| 03 Oct 2023 | Purchase | 10.12 Cr | ₹675 | 1.50 L | Block | 0.462411 | NSE |
| 03 Oct 2023 | Sell | 10.12 Cr | ₹675 | 1.50 L | Block | 0.462411 | NSE |
| 28 Sep 2023 | Purchase | 10.79 Cr | ₹675 | 1.60 L | Bulk | 0.492957 | NSE |
| 28 Sep 2023 | Sell | 13.18 Cr | ₹675.02 | 1.95 L | Bulk | 0.602074 | NSE |
| 09 May 2023 | Purchase | 34.21 Cr | ₹495.25 | 6.91 L | Bulk | 2.129731 | NSE |
| 09 May 2023 | Sell | 44.12 Cr | ₹495.27 | 8.91 L | Bulk | 2.746278 | NSE |
| 16 Aug 2021 | Purchase | 23.54 Cr | ₹1,023.34 | 2.30 L | Bulk | 0.70903 | NSE |
Insider trading & SAST
Client name
Krsna Diagnostics (Mumbai) Pvt Ltd
Krsna Diagnostics (Mumbai) Private Limited
Krsna Diagnostics (Mumbai) Private Limited
Icici Prudential Mutual Fund
Tata Small Cap Fund & Tata India Equity Fund Multipartner Sicav
Tata Small Cap Fund & Tata India Equity Fund Multipartner Sicav
Icici Prudential Mutual Fund
Phi Capital Trust - Phi Capital Growth Fund - 1
Phi Capital Trust - Phi Capital Growth Fund - 1
Krsna Diagnostics (Mumbai) Private Limited
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 Jan 2025 | Promoter | Acquisition | 0.07 | 2.37 | 0 | — | 22.93 K | 27 Dec 2024 | Market | 7,65,685 | SAST | 29(2) | — |
| 31 Dec 2024 | Promoter Group | Acquisition | 0.07101 | 2.37 | 2 Cr | ₹870.89 | 22.93 K | 27 Dec 2024 | Market Purchase | 7,65,685 | Insider Trading | — | Equity Shares |
| 06 Jun 2024 | Promoter Group | Acquisition | 0.139363 | 2.3 | 2.43 Cr | ₹540.86 | 45 K | 04 Jun 2024 | Market Purchase | 7,42,756 | Insider Trading | — | Equity Shares |
| 06 Feb 2024 | Other | Disposal | 2.08 | 3.01 | 0 | — | 6.28 L | 14 Dec 2022 - 01 Feb 2024 | Market | -9,71,138 | SAST | 29(2) | — |
| 25 Oct 2023 | Other | Acquisition | 0.19 | 7.17 | 0 | — | 62.68 K | 23 Oct 2023 | Market | 22,53,012 | SAST | 29(1) | — |
| 27 Mar 2023 | Other | Acquisition | 0.03 | 5.02 | 0 | — | 12.13 K | 22 Mar 2023 | Market | 15,78,573 | SAST | 29(1) | — |
| 20 Dec 2022 | Other | Acquisition | 1.51 | 5.09 | 0 | — | 4.76 L | 13 Dec 2022 | Market | 15,98,966 | SAST | 29(1) | — |
| 04 Jan 2022 | Connected Person | Acquisition | 0.079623 | 15.5 | 1.82 Cr | ₹727.58 | 25 K | 31 Dec 2021 | Market Purchase | 48,68,040 | Insider Trading | — | Equity Shares |
| 04 Jan 2022 | Connected Person | Acquisition | 0.238869 | 15.42 | 5.58 Cr | ₹743.87 | 75 K | 30 Dec 2021 | Market Purchase | 48,43,040 | Insider Trading | — | Equity Shares |
| 14 Sep 2022 | Promoter Group | Acquisition | 0.414039 | 2.22 | 6.66 Cr | ₹512.29 | 1.30 L | 12 Sep 2022 | Gift | 6,97,756 | Insider Trading | — | Equity Shares |
Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
Krsnaa Diagnostics Limited is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical
Corporate Actions
Date
Type
Details
Company details
Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Krsnaa Diagnostics Share Price
551.25-8.80 (-1.57%)
-36.36% past 1 Year
News
Krsnaa Diagnostics posts lower Q1 profit on higher revenue
Equity
KRSNAA
Krsnaa Diagnostics reports higher Q1 EBITDA with lower margin
Equity
KRSNAA
Krsnaa Diagnostics posts marginally higher Q4 EBITDA with stable margins YoY
Equity
KRSNAA
Krsnaa Diagnostics Q4 FY earnings show strong profit growth on steady revenue base
Equity
KRSNAA
Krsnaa Diagnostics reports Profit after tax of 43.38 Crores, in the March 2026 quarter
Equity
KRSNAA
Krsnaa Diagnostics appoints Chandra Prakash Singh as Interim CFO from April 17, 2026.
Equity
KRSNAA
Krsnaa Diagnostics submits newspaper advertisement
Equity
KRSNAA
Krsnaa Diagnostics submits notice of postal ballot
Equity
KRSNAA
Krsnaa Diagnostics informs about analyst meet
Equity
KRSNAA
Krsnaa Diagnostics raises Rs 430 crore via NCDs
Equity
KRSNAA
Krsnaa Diagnostics Issues Rs 430 Crores Debentures to Asian Development Bank for 7-Year Term.
Equity
KRSNAA
Krsnaa Diagnostics informs about analyst meet outcome
Equity
KRSNAA
Krsnaa Diagnostics - Quaterly Results
Equity
KRSNAA
Krsnaa Diagnostics Q3 EBITDA Up 3.1% YoY to Rs 46.50 Crores, Margin Slightly Down to 25.66%.
Equity
KRSNAA
Krsnaa Diagnostics Q3FY26 Results: Revenue Growth Offsets Profit Decline
Equity
KRSNAA
Krsnaa Diagnostics reports Profit after tax of 16.49 Crores, in the December 2025 quarter
Equity
KRSNAA
Krsnaa Diagnostics to Meet Analysts/Investors on January 8 at 1 PM.
Equity
KRSNAA
Krsnaa Diagnostics informs about compliances-certificate
Equity
KRSNAA
Krsnaa Diagnostics informs about closure of trading window
Equity
KRSNAA
Krsnaa Diagnostics board clears Rs 430 crores fundraise via NCD issuance
Equity
KRSNAA

